# KLOW Peptide: Ingredients, Dosage, and When to Split Vials
> Note: PeptIQ is not a medical provider. This article is for educational purposes only. Consult a qualified healthcare professional before starting any peptide protocol.
Answer first: KLOW is a research-community nickname for a recovery blend that usually combines BPC-157, TB-500, GHK-Cu, and KPV in one vial (sometimes described as GLOW plus KPV). There is no randomized trial of "KLOW" as a labeled product. Community milligram tables and pin calendars are component folklore plus listing math, not a protocol.
People search "klow," "klow peptide," and "klow peptide dosage" when they want composition, typical pin ranges, frequency, and whether the blend beats separate vials. This hub covers that cluster in one URL.
What's in KLOW?
KLOW is a compound blend typically containing:
- BPC-157 (Body Protection Compound 157) — 300–500mcg per dose
- TB-500 (Thymosin Beta-4 or TB4-Frag 17–23) — 2–2.5mg per dose
- GHK-Cu (Copper peptide GHK-Cu) — 1–2mg per dose
- KPV (Lys-Pro-Val tripeptide) — often 200–500mcg per dose in four-way blends
Supplier ratios vary. When KPV is omitted, the blend is closer to the three-way GLOW stack naming people use online.
| Compound | Primary Action |
|---|---|
| BPC-157 | Tissue healing, gut repair, tendon/ligament regeneration, anti-inflammatory |
| TB-500 | Actin binding, tissue flexibility, muscle fiber repair, anti-fibrotic |
| GHK-Cu | Collagen synthesis, wound healing, anti-inflammatory, gene expression regulation |
Together, they cover tissue repair from multiple angles — which is why the stack is popular for musculoskeletal injuries, surgical recovery, and general maintenance.
Evidence tier (read this before any dosage table)
| Layer | What it can support | What it cannot |
|---|---|---|
| Component papers | Separate biologies for BPC-157, thymosin beta-4, and GHK-Cu | A blended milligram calendar |
| Supplier listings | Claimed fill weights and suggested pin counts | Identity or potency of the cake |
| Community and in-app logs | Frequency people record | Efficacy |
BPC-157 reviews remain preclinical-heavy (PubMed 29569996). Thymosin beta-4 wound-healing reviews describe the parent peptide, not every TB-500 fragment listing (PubMed 20507180). GHK-Cu has a broader skin and gene-expression literature, still not a blend schedule.
Who Uses KLOW?
KLOW (and its close cousin GLOW, which has slightly different compound ratios) is popular among:
- People recovering from tendon, ligament, or muscle injuries
- Joint pain (osteoarthritis, tendinitis, bursitis)
- Post-surgical recovery acceleration
- General anti-aging maintenance (collagen support, tissue integrity)
- Athletes doing heavy training who want an ongoing recovery baseline
It's often used as a standalone protocol for 8–12 weeks during an acute recovery phase, then cycled off and used for maintenance at lower frequency.
Standard KLOW Dosing Protocol
Typical usage for active injury recovery (community framing, not a trial arm):
- Frequency: 4–5x per week (or daily for acute phases)
- Duration: 8–12 weeks loading, then maintenance at 2–3x/week
- Route: SubQ injection in the lower abdomen or near the target tissue
- Reconstitution: Standard BAC water, often 2mL per vial in write-ups
For maintenance (not acute injury):
- 2–3x per week is commonly discussed for ongoing collagen support
What "a dose" usually means on a listing
Blend vials are sold as a single lyophilized mass. Educational math still uses:
Concentration = labeled total milligrams ÷ diluent milliliters
That total is not one peptide. A draw labeled "one dose" on a forum is a share of whatever ratio the filler used. Change the water volume and the unit count moves even if the story stays "same dose."
If a vial is described as a multi-milligram blend and someone adds 2 mL bacteriostatic water, community write-ups often treat 0.2–0.5 mL as a "typical draw." Those volumes only mean something if the label ratio is true. They are not a recommended mix.
Frequency people discuss
| Context people name | Cadence they repeat | Honest reading |
|---|---|---|
| Acute recovery story | Several days per week, sometimes daily | Uncontrolled habit |
| Maintenance story | 2–3 days per week | Uncontrolled habit |
| Cycle length story | 8–12 weeks, then time off | Forum calendar, not a trial arm |
"How often to take KLOW peptide" has no literature answer. Component half-life stories conflict: BPC-157 is discussed as shorter-acting, TB-500 as less frequent, GHK-Cu as daily or cycled. Stuffing three stories into one syringe does not reconcile them.
KLOW vs. GLOW: What's the Difference?
GLOW is a variant with a different formulation ratio — typically with more GHK-Cu relative to BPC-157, making it lean slightly more toward collagen/skin and anti-aging applications.
- KLOW → repair + recovery (higher BPC-157/TB-500 emphasis)
- GLOW → collagen + longevity (higher GHK-Cu emphasis)
In practice, both are used interchangeably for most recovery applications. The difference is subtle and vendor-dependent — always check the actual compound ratios on your specific product.
Side Effects: The Water Retention Issue
The most commonly reported side effect with KLOW is pitting edema — water retention that shows up as mild swelling, particularly in the thighs, calves, or hands.
